Infection Factor Assay
AssigneeUniversity of Exeter
InventorsAndrea J. Dowling, Richard H. Ffrench-Constant
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Exeter
InventorsAndrea J. Dowling, Richard H. Ffrench-Constant
Estimating the term…
There is provided a method of selecting an anti-macrophage micro-organism comprising an anti-macrophage factor, the method comprising the steps of: a) obtaining an assay micro-organism and preparing a sample thereof; b) lysing the assay micro-organism cells contained in the sample from (a) to form a lysate fluid; c) contacting a sample of macrophage cells with the lysate fluid from step (b); d) determining the macrophage cell viability and comparing the viability to the viability of macrophage cells in a control macrophage sample; and e) selecting the micro-organism as an anti-macrophage micro-organism if the viability is reduced by at least 10%. The anti-macrophage factors identifiable by methods according to the invention can be used in the formulation of vaccines and other therapies against disorders caused by the anti-macrophage micro-organism.
A method of selecting an anti-macrophage micro-organism comprising an anti-macrophage factor, the method comprising the steps of:
An anti-macrophage factor comprising an amino acid sequence comprising one or more of SEQ ID NOs:1-9.
A polynucleotide encoding one or more of the amino acid sequences SEQ ID NOs:1-9.
Dependencies are inferred from the claim text.